The Hellenic Association of Pharmaceutical Companies (SFEE) and its member companies producing or marketing vaccines are engaging in constant and close cooperation with the Ministry of Health, the National Vaccination Committee and all interested parties on the matter of the availability of certain childhood vaccines.
The Greek Association says it is doing its best to help address any challenges and safeguard the smooth and uninterrupted supply of childhood vaccines in Greece in conformity with high quality and safety standards.
Childhood vaccine shortages are a global phenomenon, due both to the rapid rise in demand – as a result of a combination of growing world population and increasing access to vaccination coverage and health care worldwide – and the lead times necessary for developing and assessing the quality and safety of each new set of vaccines, which can be up to 2.5 years.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze